224 related articles for article (PubMed ID: 34285139)
1. Endothelial microparticle-associated protein disulfide isomerase increases platelet activation in diabetic coronary heart disease.
Sun XD; Han L; Lan HT; Qin RR; Song M; Zhang W; Zhong M; Wang ZH
Aging (Albany NY); 2021 Jul; 13(14):18718-18739. PubMed ID: 34285139
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cells microparticle-associated protein disulfide isomerase promotes platelet activation in metabolic syndrome.
Fan GQ; Qin RR; Li YH; Song DJ; Chen TS; Zhang W; Zhong M; Zhang Y; Xing YQ; Wang ZH
Oncotarget; 2016 Dec; 7(50):83231-83240. PubMed ID: 27825126
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation in diabetic mice models: the role of vascular endothelial cell-derived protein disulfide isomerase-mediated GP IIb/IIIa receptor activation.
Qin RR; Zhu H; Wang F; Song M; Lin PL; Xing YQ; Zhang W; Zhong M; Wang ZH
Aging (Albany NY); 2019 Aug; 11(16):6358-6370. PubMed ID: 31437127
[TBL] [Abstract][Full Text] [Related]
4. Protein disulphide isomerase in platelet function.
Manickam N; Sun X; Li M; Gazitt Y; Essex DW
Br J Haematol; 2008 Jan; 140(2):223-9. PubMed ID: 18028487
[TBL] [Abstract][Full Text] [Related]
5. HPW-RX40 prevents human platelet activation by attenuating cell surface protein disulfide isomerases.
Kung PH; Hsieh PW; Lin YT; Lee JH; Chen IH; Wu CC
Redox Biol; 2017 Oct; 13():266-277. PubMed ID: 28600983
[TBL] [Abstract][Full Text] [Related]
6. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange.
Lahav J; Jurk K; Hess O; Barnes MJ; Farndale RW; Luboshitz J; Kehrel BE
Blood; 2002 Oct; 100(7):2472-8. PubMed ID: 12239158
[TBL] [Abstract][Full Text] [Related]
7. Platelet microparticle-associated protein disulfide isomerase promotes platelet aggregation and inactivates insulin.
Raturi A; Miersch S; Hudson JW; Mutus B
Biochim Biophys Acta; 2008 Dec; 1778(12):2790-6. PubMed ID: 18691554
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking-assisted screening reveals tannic acid as a natural protein disulphide isomerase inhibitor with antiplatelet and antithrombotic activities.
Ren L; You T; Li Q; Chen G; Liu Z; Zhao X; Wang Y; Wang L; Wu Y; Tang C; Zhu L
J Cell Mol Med; 2020 Dec; 24(24):14257-14269. PubMed ID: 33128352
[TBL] [Abstract][Full Text] [Related]
9. A humanized monoclonal antibody that inhibits platelet-surface ERp72 reveals a role for ERp72 in thrombosis.
Holbrook LM; Sandhar GK; Sasikumar P; Schenk MP; Stainer AR; Sahli KA; Flora GD; Bicknell AB; Gibbins JM
J Thromb Haemost; 2018 Feb; 16(2):367-377. PubMed ID: 29052936
[TBL] [Abstract][Full Text] [Related]
10. Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive study.
Mörtberg J; Lundwall K; Mobarrez F; Wallén H; Jacobson SH; Spaak J
BMC Nephrol; 2019 Mar; 20(1):71. PubMed ID: 30823870
[TBL] [Abstract][Full Text] [Related]
11. The b' domain of protein disulfide isomerase cooperates with the a and a' domains to functionally interact with platelets.
Wang L; Zhou J; Wang L; Wang CC; Essex DW
J Thromb Haemost; 2019 Feb; 17(2):371-382. PubMed ID: 30566278
[TBL] [Abstract][Full Text] [Related]
12. Platelet protein disulfide isomerase is required for thrombus formation but not for hemostasis in mice.
Kim K; Hahm E; Li J; Holbrook LM; Sasikumar P; Stanley RG; Ushio-Fukai M; Gibbins JM; Cho J
Blood; 2013 Aug; 122(6):1052-61. PubMed ID: 23788140
[TBL] [Abstract][Full Text] [Related]
13. Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation.
Essex DW; Li M; Miller A; Feinman RD
Biochemistry; 2001 May; 40(20):6070-5. PubMed ID: 11352743
[TBL] [Abstract][Full Text] [Related]
14. Juglone prevents human platelet aggregation through inhibiting Akt and protein disulfide isomerase.
Kao CC; Kung PH; Tai CJ; Tsai MC; Cheng YB; Wu CC
Phytomedicine; 2021 Feb; 82():153449. PubMed ID: 33387969
[TBL] [Abstract][Full Text] [Related]
15. PAR-4/Ca
Giannella A; Ceolotto G; Radu CM; Cattelan A; Iori E; Benetti A; Fabris F; Simioni P; Avogaro A; Vigili de Kreutzenberg S
Cardiovasc Diabetol; 2021 Apr; 20(1):77. PubMed ID: 33812377
[TBL] [Abstract][Full Text] [Related]
16. Bacitracin reveals a role for multiple thiol isomerases in platelet function.
Robinson A; O'Neill S; Kiernan A; O'Donoghue N; Moran N
Br J Haematol; 2006 Feb; 132(3):339-48. PubMed ID: 16409299
[TBL] [Abstract][Full Text] [Related]
17. Platelet-targeting thiol reduction sensor detects thiol isomerase activity on activated platelets in mouse and human blood under flow.
Zhu S; Welsh JD; Brass LF; Diamond SL
J Thromb Haemost; 2016 May; 14(5):1070-81. PubMed ID: 26725377
[TBL] [Abstract][Full Text] [Related]
18. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome.
Li X; Cong H
Tex Heart Inst J; 2009; 36(2):134-9. PubMed ID: 19436807
[TBL] [Abstract][Full Text] [Related]
20. Platelet activity and hypercoagulation in type 2 diabetes.
Pretorius L; Thomson GJA; Adams RCM; Nell TA; Laubscher WA; Pretorius E
Cardiovasc Diabetol; 2018 Nov; 17(1):141. PubMed ID: 30388964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
